Journals / Türk Kardiyoloji Derneği Arşivi / 2009 / Cilt: 37 - Sayı: 3

Yüksek serum gama-glutamiltransferaz aktivitesi ile yavaş koroner akım arasındaki ilişki

Relationship between elevated serum gamma-glutamyltransferase activity and slow coronary flow

Pages
168–173
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The use of medi- cations was significantly more common in the CAD group(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We evaluated the relationship between coronary blood flow and serum gamma-glutamyltransferase(GGT) activity in patients with slow coronary flow (SCF).Study design: The study included 90 patients (47 men,43 women; mean age 50.8±9.4 years) with SCF and 88patients (45 men, 43 women; mean age 51.4±8.8 years)with coronary artery disease (CAD), whose diagnoses weremade by coronary angiography.
📊
Key Findings & Data:The resultswere compared with those of a control group consisting of86 age- and sex-matched patients who had normal coronaryarteries and normal coronary flow.
💡
Conclusion & Impact:The use of medi- cations was significantly more common in the CAD group(p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We evaluated the relationship between coronary blood flow and serum gamma-glutamyltransferase(GGT) activity in patients with slow coronary flow (SCF).Study design: The study included 90 patients (47 men,43 women; mean age 50.8±9.4 years) with SCF and 88patients (45 men, 43 women; mean age 51.4±8.8 years)with coronary artery disease (CAD), whose diagnoses weremade by coronary angiography. Patients with CAD had nor- mal coronary flow. Coronary flow was quantified using thecorrected TIMI frame count (TFC) method and serum levelsof gamma-glutamyltransferase were measured. The resultswere compared with those of a control group consisting of86 age- and sex-matched patients who had normal coronaryarteries and normal coronary flow. Results: The three groups were similar with respect tobody mass index, presence of hypertension and diabetesmellitus, lipid profiles, and fasting glucose. The use of medi- cations was significantly more common in the CAD group(p

Özet

Amaç: Çalışmamızda yavaş koroner kan akımı (YKA) olan hastalarda serum gama-glutamiltransferaz (GGT) aktivitesi ile koroner kan akımı arasındaki ilişki araştırıldı. Ça­lış­ma pla­nı: Çalışmaya YKA saptanan 90 hasta (47 erkek, 43 kadın; ort. yaş 50.8±9.4) ve koroner arter hastalığı (KAH) olan 88 hasta (45 erkek, 43 kadın; ort. yaş 50.8±9.4) alındı. Yavaş koroner kan akımı ve KAH tanıları koroner anjiyografi ile kondu. Koroner arter hastalığı olan grupta normal koroner akım vardı. Tüm hastalarda koroner akım düzeltilmiş TIMI kare sayısı ile değerlendirildi ve serum GGT düzeyleri ölçüldü. Sonuçlar, yaş ve cinsiyet uyumlu ve koroner arterleri ve koroner akımı normal bulunan 86 hastadan oluşan kontrol grubuyla karşılaştırıldı. Bul­gu­lar: Gruplar arasında beden kütle indeksi, hipertansiyon ve diyabet varlığı, lipit profili ve açlık kan şekeri açısından fark yoktu. Koroner arter hastalığı olan grupta ilaç kullanımı anlamlı derecede fazlaydı (p

🔖

Cite This Article

MADEN, O., DEMİR, A. D., BAŞAR, N., ÖZLÜ, M. F., GÜNGÖR, Ö., MALÇOK, Ö., ERBAY, A. R., ÖZCAN, F., ŞEN, N., TURAK, O., ÇAĞLI, K. (2022). Yüksek serum gama-glutamiltransferaz aktivitesi ile yavaş koroner akım arasındaki ilişki. Türk Kardiyoloji Derneği Arşivi, Cilt: 37 - Sayı: 3, 168–173. https://ajindex.com/articles/633372

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Tambe AA, Demany MA, Zimmerman HA, Mascarenhas E. Angina pectoris and slow flow velocity of dye in coronary arteries-a new angiographic finding. Am Heart J 1972;84:66-71
  2. Pekdemir H, Cin VG, Çiçek D, Çamsarı A, Akkuş N, Döven O, et al. Slow coronary flow may be a sign of diffuse atherosclerosis. Contribution of FFR and IVUS. Acta Cardiol 2004;59:127-33
  3. Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-81
  4. Tawakol A, Omland T, Gerhard M, Wu JT, Creager MA. Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997;95:1119-21
  5. Mosseri M, Yarom R, Gotsman MS, Hasin Y. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986;74:964-72
  6. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predic tor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358-66
  7. Emdin M, Passino C, Michelassi C, Titta F, L’abbate A, Donato L, et al. Prognostic value of serum gammaglutamyl transferase activity after myocardial infarction. Eur Heart J 2001;22:1802-7
  8. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, et al. TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996;93:879-88
  9. Mangieri E, Macchiarelli G, Ciavolella M, Barillà F, Avella A, Martinotti A, et al. Slow coronary flow: clinical and histopathological features in patients with otherwise normal epicardial coronary arteries. Cathet Cardiovasc Diagn 1996;37:375-81
  10. De Bruyne B, Hersbach F, Pijls NH, Bartunek J, Bech JW, Heyndrickx GR, et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “Normal” coronary angiography. Circulation 2001;104:2401-6
  11. Li JJ, Xu B, Li ZC, Qian J, Wei BQ. Is slow coronary flow associated with inflammation? Med Hypotheses 2006;66:504-8
  12. Turhan H, Saydam GS, Erbay AR, Ayaz S, Yaşar AS, Aksoy Y, et al. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow. Int J Cardiol 2006;108:224-30
  13. Lanza GA, Andreotti F, Sestito A, Sciahbasi A, Crea F, Maseri A. Platelet aggregability in cardiac syndro